Desk›Healthcare› Kimia Biosciences Ltd
Kimia Biosciences Ltd
BSE 530313 · NSE KIMIABL · ISIN INE285U01025 · Group X · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹28.50
+2.15%
BSE close, 28 August 2026
₹134.84 cr
4.7 cr shares · Micro cap
₹33.79 cr
as published
18.8× · 40.14×
EPS ₹1.52 · BV ₹0.71
114.88 / 7.43
₹ cr, as filed
13
3 selected · 23%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -34.1% |
|---|---|
| Against 52-week low | +22.8% |
| Day change | +2.15% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹1.52 |
|---|---|
| Price / earnings | 18.75× |
| Price / book | 40.14× |
| Book value — derived, price ÷ P/B | ₹0.71 |
| Return on equity | 212.52% |
| Operating margin | 11.72% |
| Net margin | 1.72% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 214.08%
- ROE as published
- 212.52%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 20.72 | 0.36 | 0.08 | 11.72% | 1.72% |
| Mar-26 · Q | 27.20 | 0.37 | 0.15 | 13.50% | 1.37% |
| FY25-26 | 114.88 | 7.43 | 1.64 | 13.83% | 6.47% |
Quarter on quarter
- Revenue, quarter on quarter
- -23.8%
- Net profit, quarter on quarter
- -2.7%
- Operating margin, quarter on quarter
- -178 bps
Disclosure profile 13 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| AGM / EGM | 3 |
| Newspaper Publication | 3 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Outcome | 1 |
| Record Date | 1 |
| Procedural sub-total | 10 |
| Total | 13 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
13 filings · 3 selected · busiest 2026-09-04
Filing rhythm · the twelve most recent
2026-08-102026-09-29
SelectedProcedural
Filings
13 in the window
-
29 September 2026 ·
Change in Management
Intimation under regulation 30 of LODR Regulation - Change in Management pursuant to approval of members at 33rd Annual General Meeting of the Company.
Company Update / Change in Management View filing →
-
29 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Declaration of Results of Remote E voting and Evoting at AGM held on 28.09.2026 along with Scruitiniser Report provided by Maya Sharma and Associates Company secretaries under regulation ....
AGM/EGM / AGM View filing →
-
28 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Submission of proceedings of the 33rd Annual General Meeting pursuant to regulations 30 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015
AGM/EGM / AGM View filing →
-
7 September 2026 ·
Newspaper Publication
Submission of Newspaper cutting of publication of 33rd AGM Notice of Kimia Biosciences Limited confirming dispatch of AGM Notice of the Company
Company Update / Newspaper Publication View filing →
-
4 September 2026 ·
Reg. 34 (1) Annual Report.
Thirty Third Annual Report for the Financial Year 2025-2026 of Kimia Biosciences Limited
Others / Reg. 34 (1) Annual Report View filing →
-
4 September 2026 ·
Intimation Of Cut-Off Date/ Record Date, E-Voting And AGM Date For The 33Rd Annual General Meeting.
Intimation of Cut off Date/ Record Date, E-Voting and AGM date for the 33rd Annual General Meeting
Corp. Action / Record Date View filing →
-
4 September 2026 ·
Newspaper Publication
Submission of Pre dispatch Newspaper Advertisement of ensuing 33rd AGM to be held on 28 September 2026 at 3.00 P.M. through Video Conferencing/ other audio Visual Means (VC/OAVM)
Company Update / Newspaper Publication View filing →
-
4 September 2026 ·
Intimation Of 33Rd Annual General Meeting Of The Company Proposed To Be Held On September 28, 2026 At 3:00 P.M. Through Video Conferencing/Other Audio Visual Means.
Intimation of 33rd Annual General Meeting of the Company proposed to be held on September 28, 2026 at 03:00 P.M. through Video Conferencing/ Other Audio Visual Means.
AGM/EGM / AGM View filing →
-
3 September 2026 ·
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On September 03, 2026 Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Outcome of the Meeting of the Board of Directors held on September 03, 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Others / Outcome without intimation View filing →
-
12 August 2026 ·
Newspaper Publication
Newspaper publication unaudited Financial Results for the Quarter Ended 30 June, 2026
Company Update / Newspaper Publication View filing →
-
10 August 2026 ·
Unaudited Financial Results For The First Quarter Ended June 30, 2026
Approval of unaudited financial result (Standalone) for quarter ended june 30, 2026.
Result / Financial Results View filing →
-
10 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On August 10, 2026 (Monday)
Pursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed herewith: 1. Unaudited ....
Board Meeting / Outcome of Board Meeting View filing →
-
3 August 2026 ·
Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations, 2015 -Intimation Of Meeting Of Board Of Directors.
Kimia Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....
Board Meeting / Board Meeting View filing →
RSS feed for Kimia Biosciences Ltd · the 50 most recent filings